Shots: The approval is based on P-III IMpower130 study assessing Tecentriq + CT vs CT as monothx. in 681 chemotherapy-naïve patients with stage IV metastatic non-sq NSCLC with no EGFR […]readmore
Tags : Metastatic Non-Squamous Non-Small Cell Lung Cancer
Regulatory
Roche’s Tecentriq (atezolizumab) Combination Therapy Receives Health Canada’s Approval for
Shots: The approval is based on P-III IMpower150 study results assessing Tecentriq + CT (carboplatin and paclitaxel) with/without Avastin (bevacizumab) vs Bevacizumab and CT in 1,202 patients in a ratio […]readmore